January 2026

1 January 2026

Opportunities for Youth : Pharma, Biotechnology, Microbiology Internship in Defence Research

Pursuing M.Sc. or equivalent (03rd/04thSem)/ B.Tech Biological Sciences (Biotechnology/ Microbiology/ Pharmacology/ Toxicology/ Immunology)

1 January 2026

Pharmacy Services & Peripheral Campuses Hiring Pharmacist

D.Pharm / B.Pharm ; Candidates with Typing and Computer skills will be preferred. Who have completed one year traineeship in the Department of Pharmacy.

1 January 2026

Opportunity in ANRF-PMECRG project for Life Sciences, Biotechnology at NIPGR

Candidate having Masters degree in Bioinformatics / Biotechnology / Botany / Life Sciences / Plant Molecular Biology or equivalent.

1 January 2026

Interview for the post of Researcher at Institute of Liver & Biliary Sciences

First class post graduate degree, including the integrated PG degrees or Second class post graduate degree, including the integrated PG degree with PhD.

1 January 2026

Fellowship opportunities in National Institute for Plant Biotechnology

Masters degree in the areas of Plant/ Agricultural Biotechnology and Molecular Biology, Plant Biotechnology, Plant Molecular Biology, Plant Biochemistry, Genetics and Plant breeding and related Biological Sciences.

1 January 2026

Macleods Walk In Drive for MPharm, MSc in Analytical Method Development, Bulk Drugs

Experience of Literature Survey, Identification of route of synthesis, Process optimization with respect to cost& quality scale up, documentation & characterization

1 January 2026

Interview for BPharm, BSc Freshers & Experience at Ipca

Handling and Reviewing of the documents related to instrument Le HPLC- Dissolution

1 January 2026

Walk in Drive for QC, QA, Production at Viatris Company - MPharm, BPharm, MSc apply

Mylan Laboratories Limited (A Viatris Company) is hiring for its OSD Manufacturing Facility at Pithampur, Indore.

1 January 2026

Peptides in Cosmetics

Vinay Kumar Singh.
Head-Formulation
Kumar Organic Products Research Centre Pvt. Ltd.,
Bengaluru
Email : formulation_krc@kopresearchcentre.net

1 January 2026

Johnson & Johnson Finalizes USD 3.05B Halda Therapeutics Acquisition to Accelerate Next-Gen Cancer Therapies

Johnson & Johnson has officially completed its acquisition of Halda Therapeutics OpCo, Inc., a clinical-stage biotechnology company known for its innovative cancer-targeting technology, in a deal valued at USD 3.05 billion in cash.